DSD-T015

Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T015

DSD-T015 · Congenital adrenal hyperplasia (CAH) · 1985 · Automated translation

Karyotype 46,XY

Classic 11β-hydroxylase deficiency (CYP11B1 W116C homozygous), detected by second-tier LC-MS/MS in newborn screening.

Case fields and evidence

Category

Congenital adrenal hyperplasia (CAH)

Age

Neonate (newborn screening blood spot at 36 hours of life, recalled at 10 days of life).

Sex

Male (full-term male infant).

Karyotype

46,XY

Diagnosis

Classic 11β-hydroxylase deficiency (CYP11B1 W116C homozygous), detected by second-tier LC-MS/MS in newborn screening.

Follow-up

Not reported in the original.

General phenotype

Male neonate; external genital phenotype not described in detail in the original; early diagnosis can prevent precocious puberty, accelerated bone age, and hypertension.

Imaging

Not reported in the original.

Laboratory findings

Immunoassay 17-OHP 72.8 nmol/l; LC-MS/MS 17-OHP 13.2/6.3/12.3 nmol/l (normal), 11-deoxycortisol 525/324/1,188 nmol/l (reference <8.60), cortisol 11.4/14.6/14.1 nmol/l (low), androstenedione 39.6 nmol/l, testosterone 5.2 nmol/l, DOC 5.0 nmol/l (16.8 after ACTH stimulation).

Management

Early hydrocortisone treatment to prevent precocious puberty, accelerated bone age, and hypertension (the original states the rationale for treatment; specific doses not reported).

Pathology

Not reported in the original.

Evidence level

See source

Clinical history

See source

Family history

See source

Puberty / Tanner

See source

Limitations

See source

Cite this resource

DSD Research Library | Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T015 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T015?version=v1.4.0